Michael Schofbanker
Von Esmarch Str. 56
Muenster, NW 48149, Germany
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients.
Journal: Vaccines
Published: April 22, 2025
Antiviral activity against HSV-1 of triterpene saponins from Anagallis arvensis is related tothe fusion-inhibitory activity of desglucoanagalloside B.
Journal: Fitoterapia
Published: November 25, 2024
Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis.
Journal: Npj viruses
Published: September 03, 2024
Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion.
Journal: Planta medica
Published: June 17, 2024
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.
Journal: PLoS pathogens
Published: February 05, 2024
Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells.
Journal: Biomolecules
Published: January 05, 2023
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 23, 2022
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Journal: Cellular and molecular life sciences : CMLS
Published: September 27, 2021
Estrogen Receptors Alpha and Beta Mediate Synaptic Transmission in the PFC and Hippocampus of Mice.
Journal: International journal of molecular sciences
Published: December 15, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026